Tel: 123.456.7890

At 达仁 DaRen Biotech, our patented CAR-T immunotherapies kill 80% of cancers.

 

We leverage the existing immune system to fight cancer and other pathogens through our diversified pipeline of new generation Immunotherapy products.

Control

T Cells

24 hours of T-Cells With Liver Cancer Cells

Our DR CAR-T

DR CAR-T Cells

24 hours of DR CAR-T Cells With Liver Cancer Cells

 
Solid tumours

Solid tumours create a protective barrier of T-reg cells to stop any CAR-T cells from being effective. DaRen has evidence that our DR CAR-T will wipe out the T-regs allowing the DR CAR-T to penetrate the tumour.

Screenshot 2020-06-24 at 3.55.06 PM.png

Our CAR-T

Broad targeting

We target a variety of markers on the cancer surface with one CAR-T, making it nearly impossible for the cancer to escape via heterogeneity. This also allows DaRen to Target 80% of all cancers with one CAR-T.

Screenshot 2020-06-24 at 3.55.01 PM.png
No Toxicity

Our CAR-T specifically targets cancer cells and does not target healthy cells.

Screenshot 2020-06-24 at 3.54.55 PM.png
At DaRen we utilize natural pathways to achieve harmony within our bodies. Our products leverage our immune system to gently and effectively fight cancer and disease without the use of chemicals or radiation. Our CAR-T products are all inspired by nature, and use native components. 
Embryonic Stem Cells
QGY7703 FH-1 AF 2 1000ms.tif
Screenshot 2020-12-13 at 11.59.01 AM.png

Partners

hkstp.png
SND.jpeg
ust bw Screenshot 2020-04-16 at 11.10.20
Screenshot 2020-04-16 at 11.18.36 PM.png
ssph_logo.jpg
beida #1 hospital.jpg
bdhospital.jpeg